Literature DB >> 18204915

Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study.

Deborah H Kwon1, Randolph M Setser, Zoran B Popović, Maran Thamilarasan, Srikanth Sola, Paul Schoenhagen, Mario J Garcia, Scott D Flamm, Harry M Lever, Milind Y Desai.   

Abstract

BACKGROUND: Patients with hypertrophic cardiomyopathy (HCM) are predisposed to ventricular tachyarrhythmia (VT); likely due to myocardial fibrosis or disarray. Delayed hyperenhancement magnetic resonance imaging (DHE-MRI) accurately detects myocardial fibrosis (scar). We sought to determine the association between septal thickness, myocardial scar and VT.
METHODS: Sixty-eight patients (mean age 44 years, 69% males) with documented HCM underwent cine MRI (Siemens Sonata or Avanto 1.5 T scanner, Erlangen, Germany) in short axis, 2, 3 and 4-chamber views and maximal interventricular septal thickness was recorded at end-diastole. Corresponding DHE-MR images (8-10 mm thick) were obtained, approximately 20 min after injection of 0.2 mmol/kg of Gadolinium. Scar was determined semi-automatically (as % of total myocardium) using VPT software (Siemens) and defined as intensity >2 SD above viable myocardium in a 12 segment short-axis model at apex, mid LV and base. Presence of VT (documented on ambulatory ECG monitoring) and history of sudden death were recorded.
RESULTS: One patient had a history of sudden death and 9 (13%) had VT on ambulatory ECG monitoring. On DHE-MRI, 39 (57%) patients had myocardial scar. Patients with VT had significantly higher scar %, compared to those without: 14% [6, 19] vs. 6% [0, 10], P = 0.01. On logistic regression, only the size of the scar was a significant predictor of VT (P = 0.03).
CONCLUSIONS: HCM subjects with VT have a higher % of myocardial scarring noted on DHE-MRI, independent of septal thickness or beta-blocker use.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18204915     DOI: 10.1007/s10554-008-9292-6

Source DB:  PubMed          Journal:  Int J Cardiovasc Imaging        ISSN: 1569-5794            Impact factor:   2.357


  40 in total

1.  Mechanism of left ventricular outlfow obstruction in patients with obstructive asymmetric septal hypertrophy (idiopathic hypertrophic subaortic stenosis).

Authors:  W L Henry; C E Clark; J M Griffith; S E Epstein
Journal:  Am J Cardiol       Date:  1975-03       Impact factor: 2.778

2.  IDIOPATHIC HYPERTROPHIC SUBAORTIC STENOSIS. I. A DESCRIPTION OF THE DISEASE BASED UPON AN ANALYSIS OF 64 PATIENTS.

Authors:  E BRAUNWALD; C T LAMBREW; S D ROCKOFF; J ROSS; A G MORROW
Journal:  Circulation       Date:  1964-11       Impact factor: 29.690

3.  Q waves in hypertrophic cardiomyopathy: a reassessment.

Authors:  B J Maron
Journal:  J Am Coll Cardiol       Date:  1990-08       Impact factor: 24.094

4.  Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.

Authors:  R J Kim; D S Fieno; T B Parrish; K Harris; E L Chen; O Simonetti; J Bundy; J P Finn; F J Klocke; R M Judd
Journal:  Circulation       Date:  1999-11-09       Impact factor: 29.690

5.  Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy.

Authors:  A Selcuk Adabag; Susan A Casey; Michael A Kuskowski; Andrey G Zenovich; Barry J Maron
Journal:  J Am Coll Cardiol       Date:  2005-03-01       Impact factor: 24.094

6.  Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population.

Authors:  B J Maron; I Olivotto; P Spirito; S A Casey; P Bellone; T E Gohman; K J Graham; D A Burton; F Cecchi
Journal:  Circulation       Date:  2000-08-22       Impact factor: 29.690

7.  Hypertrophic cardiomyopathy: the interrelation of disarray, fibrosis, and small vessel disease.

Authors:  A M Varnava; P M Elliott; S Sharma; W J McKenna; M J Davies
Journal:  Heart       Date:  2000-11       Impact factor: 5.994

8.  Phenotypic spectrum and patterns of left ventricular hypertrophy in hypertrophic cardiomyopathy: morphologic observations and significance as assessed by two-dimensional echocardiography in 600 patients.

Authors:  H G Klues; A Schiffers; B J Maron
Journal:  J Am Coll Cardiol       Date:  1995-12       Impact factor: 24.094

9.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy.

Authors:  B J Maron; J K Wolfson; S E Epstein; W C Roberts
Journal:  J Am Coll Cardiol       Date:  1986-09       Impact factor: 24.094

10.  Relation of electrocardiographic abnormalities and patterns of left ventricular hypertrophy identified by 2-dimensional echocardiography in patients with hypertrophic cardiomyopathy.

Authors:  B J Maron; J K Wolfson; E Ciró; P Spirito
Journal:  Am J Cardiol       Date:  1983-01-01       Impact factor: 2.778

View more
  37 in total

Review 1.  Nuclear cardiac imaging in hypertrophic cardiomyopathy.

Authors:  Jamshid Shirani; Vasken Dilsizian
Journal:  J Nucl Cardiol       Date:  2011-02       Impact factor: 5.952

2.  Late gadolinium enhancement gray zone in patients with hypertrophic cardiomyopathy. Comparison of different gray zone definitions.

Authors:  Mateusz Spiewak; Lukasz A Małek; Lidia Chojnowska; Jolanta Miśko; Joanna Petryka; Mariusz Kłopotowski; Barbara Milosz; Magdalena Polańska; Witold Ruzyłło
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-27       Impact factor: 2.357

Review 3.  The role of cardiac magnetic resonance imaging in the assessment of non-ischemic cardiomyopathy.

Authors:  Mouaz H Al-Mallah; Mohammad Naseem Shareef
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

4.  Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.

Authors:  Elif Elmas; Christina Doesch; Stephan Fluechter; Miriam Freundt; Christel Weiss; Siegfried Lang; Thorsten Kälsch; Dariush Haghi; Jana Papassotiriou; Jan Kunde; Stefan O Schoenberg; Martin Borggrefe; Theano Papavassiliu
Journal:  Int J Cardiovasc Imaging       Date:  2010-09-26       Impact factor: 2.357

5.  Cardiac MRI and CT features of inheritable and congenital conditions associated with sudden cardiac death.

Authors:  Patrick Sparrow; Naeem Merchant; Yves Provost; Deirdre Doyle; Elsie Nguyen; Narinder Paul
Journal:  Eur Radiol       Date:  2008-09-16       Impact factor: 5.315

Review 6.  The prognostic value of late gadolinium enhancement CMR in nonischemic cardiomyopathies.

Authors:  Theodoros D Karamitsos; Stefan Neubauer
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

Review 7.  The Impending Dilemma of Electrocardiogram Screening in Athletic Children.

Authors:  Laure Léger; Boris Gojanovic; Nicole Sekarski; Erik J Meijboom; Yvan Mivelaz
Journal:  Pediatr Cardiol       Date:  2015-08-20       Impact factor: 1.655

8.  Ventricular arrhythmias in hypertrophic cardiomyopathy--can we ever predict them?

Authors:  Narayanan Namboodiri; Johnson Francis
Journal:  Indian Pacing Electrophysiol J       Date:  2010-03-05

9.  Mitral valve prolapse: a source of arrhythmias?

Authors:  E E van der Wall; M J Schalij
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

Review 10.  Quantification in cardiac MRI: advances in image acquisition and processing.

Authors:  Anil K Attili; Andreas Schuster; Eike Nagel; Johan H C Reiber; Rob J van der Geest
Journal:  Int J Cardiovasc Imaging       Date:  2010-02       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.